Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study Ferry Tconrad ASenneville Erouxv Sdupieux Cdinh Alustig Sgoutelle Sbriot TPham TTvalour F
Implementation of a phage therapy center in France dedicated to complex bone and joint infection: 4-year experience of multidisciplinarity and multistep interactions Ferry TKolenda Cbriot Tlustig Sbatailler Cleboucher Glaurent Fon behalf of the Lyon BJI Study group
Impact on the gut microbiota of intensive and prolonged antimicrobial therapy in patients with bone and joint infection benech Nlevast Bgasc Cbatailler CSenneville Elustig Spouderoux CBOUTOILLE Dboucihna Ldacuhy FAzeller VMaynardN CMcazanave CLe Thi TTjosse Jdoré Jlaurent FFerry Ton behalf of the OSIRIS Study Group
Isolation and characterization of a novel Jumbo phage active against the emerging ST307 carbapenemase-producing K. pneumoniae clone medina MKolenda Cbonhomme Mserain Mlegendre Tblazere Larnaud Vdortet LFerry Tlaurent Fon behalf of the PHAGEinLYON study group
Targeting coagulase negative staphylococci causing prosthetic infections with bacteriophages: can we use polyvalent anti Staphylococcus phages ? Kolenda Cmedina Mblazere Llegendre Tarnaud Vbonhomme Msimoes-martins PFerry Tlaurent Fon behalf of the PHAGEinLYON study group
Phage discovery: isolation and characterization of seventeen novel anti-Staphylococcus aureus bacteriophages Kolenda Cmedina Mlegendre Tblazere Lbonhomme Marnaud Vsouche Aroussel-gaillard Tsimoes-martins Pbes MFerry Ton behalf of the PHAGEinLYON study grouplaurent F
